Optimization of a Crude Deoxyribose-5-phosphate Aldolase Lyzate-Catalyzed Process in Synthesis of Statin Intermediates
Authors:
- 22 April 2013
- journal article
- review article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 17 (5) , 854-862
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Historic Overview and Recent Advances in the Synthesis of Super-statinsCurrent Organic Chemistry, 2010
- A historical perspective on the discovery of statinsProceedings of the Japan Academy, Series B, 2010
- Statins and cardioprotection — More than just lipid lowering?Pharmacology & Therapeutics, 2009
- Catalytic Asymmetric Carbon−Carbon Bond Formations: Their Evolution from Biocatalysis to Organocatalysis over the MillenniumOrganic Process Research & Development, 2006
- Advances in biocatalytic synthesis of pharmaceutical intermediatesCurrent Opinion in Chemical Biology, 2005
- Chemoenzymatic Synthesis of Building Blocks for Statin Side ChainsAngewandte Chemie International Edition, 2004
- Challenges in the development of an efficient enzymatic process in the pharmaceutical industryTetrahedron: Asymmetry, 2004
- Structure-Based mutagenesis approaches toward expanding the substrate specificity of d-2-Deoxyribose-5-phosphate aldolaseBioorganic & Medicinal Chemistry, 2003
- Novel Developments in Biocatalytic Organic ChemistryCurrent Organic Chemistry, 2002
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976